217 related articles for article (PubMed ID: 32075383)
1. Management of Immune-Related Endocrinopathies in Anticancer Treatment with Checkpoint Inhibitors.
Lakomý R; Poprach A; Kazda T
Klin Onkol; 2020; 33(1):15-19. PubMed ID: 32075383
[TBL] [Abstract][Full Text] [Related]
2. Endocrine toxicities of immune checkpoint inhibitors.
Wright JJ; Powers AC; Johnson DB
Nat Rev Endocrinol; 2021 Jul; 17(7):389-399. PubMed ID: 33875857
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal Toxicity of Immunotherapy.
Špaček J
Klin Onkol; 2020; 33(1):23-28. PubMed ID: 32075385
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity and Immunotherapy.
Kopecký J
Klin Onkol; 2020; 33(1):11-14. PubMed ID: 32075382
[TBL] [Abstract][Full Text] [Related]
5. [Endocrinopathies Associated with Immune Checkpoint Inhibitors].
Santos MJ
Acta Med Port; 2022 Mar; 35(3):209-215. PubMed ID: 35077347
[TBL] [Abstract][Full Text] [Related]
6. Side Effects and Efficacy of Immunotherapy.
Fiala O; Šorejs O; Šustr J; Fínek J
Klin Onkol; 2020; 33(1):8-10. PubMed ID: 32075381
[TBL] [Abstract][Full Text] [Related]
7. Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.
Barroso-Sousa R; Ott PA; Hodi FS; Kaiser UB; Tolaney SM; Min L
Cancer; 2018 Mar; 124(6):1111-1121. PubMed ID: 29313945
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know).
Ruggeri RM; Campennì A; Giuffrida G; Trimboli P; Giovanella L; Trimarchi F; Cannavò S
J Endocrinol Invest; 2019 Jul; 42(7):745-756. PubMed ID: 30471004
[TBL] [Abstract][Full Text] [Related]
9. Endocrine side effects induced by immune checkpoint inhibitors.
Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
[TBL] [Abstract][Full Text] [Related]
10. New insight in endocrine-related adverse events associated to immune checkpoint blockade.
Elia G; Ferrari SM; Galdiero MR; Ragusa F; Paparo SR; Ruffilli I; Varricchi G; Fallahi P; Antonelli A
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101370. PubMed ID: 31983543
[TBL] [Abstract][Full Text] [Related]
11. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of Renal Cell Carcinoma].
Poprach A; Lakomý R; Büchler T
Klin Onkol; 2017; 30(Supplementum3):55-61. PubMed ID: 29239194
[TBL] [Abstract][Full Text] [Related]
13. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F
Ann Endocrinol (Paris); 2018 Oct; 79(5):591-595. PubMed ID: 30056975
[TBL] [Abstract][Full Text] [Related]
14. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
Scott ES; Long GV; Guminski A; Clifton-Bligh RJ; Menzies AM; Tsang VH
Eur J Endocrinol; 2018 Feb; 178(2):173-180. PubMed ID: 29187509
[TBL] [Abstract][Full Text] [Related]
15. The side effects of immune checkpoint inhibitor therapy on the endocrine system.
Goyal I; Pandey MR; Sharma R; Chaudhuri A; Dandona P
Indian J Med Res; 2021 Apr; 154(4):559-570. PubMed ID: 35435341
[TBL] [Abstract][Full Text] [Related]
16. French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F
Endocr Relat Cancer; 2019 Feb; 26(2):G1-G18. PubMed ID: 30400055
[TBL] [Abstract][Full Text] [Related]
17. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management.
Sznol M; Postow MA; Davies MJ; Pavlick AC; Plimack ER; Shaheen M; Veloski C; Robert C
Cancer Treat Rev; 2017 Jul; 58():70-76. PubMed ID: 28689073
[TBL] [Abstract][Full Text] [Related]
18. Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians.
Hryniewicki AT; Wang C; Shatsky RA; Coyne CJ
J Emerg Med; 2018 Oct; 55(4):489-502. PubMed ID: 30120013
[TBL] [Abstract][Full Text] [Related]
19. [Endocrinopathies induced by immune checkpoint inhibitors].
Jaafar J; Mavromati M; Philippe J
Rev Med Suisse; 2018 Jan; 14(588-589):34-38. PubMed ID: 29337446
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors and endocrine side effects, a narrative review.
Agrawal L; Bacal A; Jain S; Singh V; Emanuele N; Emanuele M; Meah F
Postgrad Med; 2020 Mar; 132(2):206-214. PubMed ID: 31876444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
